Cleared Abbreviated

K071043 - BOSTON XO (HEXAFOCON A), BOSTON EO (ENFLUFOCON B) AND BOSTON ES (ENFLUFOCON A) RIGID GAS PERMEABLE CONTACT LENSES (FDA 510(k) Clearance)

Aug 2007
Decision
112d
Days
Class 2
Risk

K071043 is an FDA 510(k) clearance for the BOSTON XO (HEXAFOCON A), BOSTON EO (ENFLUFOCON B) AND BOSTON ES (ENFLUFOCON A) RIGID GAS PERMEABLE CONTACT LENSES. This device is classified as a Lens, Contact (other Material) - Daily (Class II - Special Controls, product code HQD).

Submitted by Bausch & Lomb, Inc. (Rochester, US). The FDA issued a Cleared decision on August 2, 2007, 112 days after receiving the submission on April 12, 2007.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.5916.

Submission Details

510(k) Number K071043 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 12, 2007
Decision Date August 02, 2007
Days to Decision 112 days
Submission Type Abbreviated
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code HQD - Lens, Contact (other Material) - Daily
Device Class Class II - Special Controls
CFR Regulation 21 CFR 886.5916